|
⚲
|
| Keyboard |
| Mark Rosenblum | |
|---|---|
| Firm | |
| Address | 335 Madison Avenue 3rd Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Terrarium Inc | 021-536869 | Executive Officer | 2.8 M of 5.5 M |
||
| Terrarium Studio Co Holdings LP | 021-536105 | Director | 5.6 M of 7.5 M |
||
| Salarius Pharmaceuticals Inc | 021-533510 | Executive Officer | of 10.0 M |
||
| Salarius Pharmaceuticals Inc | 021-482643 | Executive Officer | 6.0 M of 6.0 M |
||
| Nico Corp | 021-459457 | Director | 12.6 M of 12.6 M |
||
| Salarius Pharmaceuticals Inc | 021-444688 | Executive Officer | 2.3 M of 2.3 M |
||
| Urigen Pharmaceuticals Inc | 021-243661 | Executive Officer | 0.3 M of 12.4 M |
||
| Advaxis Inc | 021-188348 | Executive Officer | of 10.0 M |
||
| Advaxis Inc | 021-179326 | Executive Officer | 0.7 M | ||
| Advaxis Inc | 021-178942 | Executive Officer | 4.5 M | ||
| Advaxis Inc | 021-173932 | Executive Officer | 1.0 M | ||
| Advaxis Inc | 021-168732 | Executive Officer | 2.0 M | ||
| Advaxis Inc | 021-160513 | Executive Officer | 6.0 M | ||
| Advaxis Inc | 021-150531 | Executive Officer | 0.8 M | ||
| Advaxis Inc | 021-145752 | Executive Officer | 7.5 M of 7.5 M |
||
| Hemobiotech Inc | 021-68647 | Executive Officer | of 3.5 M |
||